Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (22)

2024

  1. Determinants of Intention to Use HIV Pre-exposure Prophylaxis and Condom Use Among a Sample of Cisgender Female Sex Workers Working Mostly Outdoors in Madrid, Spain

    Archives of Sexual Behavior, Vol. 53, Núm. 7, pp. 2817-2831

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  3. Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain

    JAMA network open, Vol. 7, Núm. 10, pp. e2438657

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain

    Communications Medicine, Vol. 3, Núm. 1

  3. Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis

    Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0133122

  4. MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

    Journal of Molecular Medicine, Vol. 101, Núm. 11, pp. 1409-1420

2022

  1. Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

    Biomedicine and Pharmacotherapy, Vol. 146

  2. Misdiagnosis rate among negative COVID-19 patients in real-life with Panbio COVID-19 antigen rapid test during 2021

    Journal of Infection

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

    Emerging microbes & infections, Vol. 11, Núm. 1, pp. 676-688

  5. Pregnancy Outcomes Among Perinatally HIV-Infected Women in Spain

    Journal of acquired immune deficiency syndromes (1999), Vol. 91, Núm. 4, pp. 373-380

  6. Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

    Journal of Infection

2021

  1. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

    Journal of Clinical Immunology, Vol. 41, Núm. 5, pp. 914-922

2020

  1. The pandemyc score. An easily applicable and interpretable model for predicting mortality associated with COVID-19

    Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-10

2019

  1. Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: A systematic review and meta-analysis

    Scientific Reports, Vol. 9, Núm. 1

  2. HIV coinfection predicts failure of ledipasvir/sofosbuvir in treatment-naïve noncirrhotic patients with HCV genotype

    Open Forum Infectious Diseases, Vol. 6, Núm. 5

2018

  1. All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real-world practice: Madrid coinfection registry findings

    Hepatology, Vol. 68, Núm. 1, pp. 32-47

2017

  1. Epidemiology and prognosis of candidaemia in elderly patients

    Mycoses, Vol. 60, Núm. 12, pp. 808-817

2014

  1. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011

    Eurosurveillance, Vol. 19, Núm. 20